Desh Rakshak Aushdhalaya has informed about the notice of Board Meeting Scheduled to be held on Thursday, l3th day of February, 2020 at 01 :00 PM, to consider and approve the Un-Audited Financial Results for the third quarter and nine months ended on December 31,2019; to Consider Limited review report given by Auditors for the third quarter and nine months ended on December 31, 2019; and any other item by the permission of the Board. Further. pursuant to SEBI (Prohibition of Insider Trading), Regulations. 2015, the trading window for dealing of securities of the Company shall remain closed for all the designated employees, Directors and connected persons of the Company from 6th February, 2020 to 15th February, 2020, for the purpose of the meeting of the Board of Directors of the Company, which is scheduled to be held on Thursday, 13th day of February, 2020, to consider and approve the Standalone Unaudited Financial Results for the third quarter and nine months ended on 31/12/2019 and other items as per agenda.
The above information is a part of company's filings submitted to BSE.
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1660.95 |
| Dr. Reddys Lab | 1223.60 |
| Cipla | 1213.85 |
| Zydus Lifesciences | 923.70 |
| Lupin | 2320.00 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: